213 related articles for article (PubMed ID: 21828270)
21. Solitary subependymal giant cell astrocytoma: Case report and review of the literature.
Corlette L; Reid A; Roberts-Thomson S; Christie M; Gaillard F
J Clin Neurosci; 2020 Dec; 82(Pt A):26-28. PubMed ID: 33317733
[TBL] [Abstract][Full Text] [Related]
22. Location-dependent maintenance of intrinsic susceptibility to mTORC1-driven tumorigenesis.
Rushing GV; Brockman AA; Bollig MK; Leelatian N; Mobley BC; Irish JM; Ess KC; Fu C; Ihrie RA
Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30910807
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.
Malik AR; Liszewska E; Skalecka A; Urbanska M; Iyer AM; Swiech LJ; Perycz M; Parobczak K; Pietruszka P; Zarebska MM; Macias M; Kotulska K; Borkowska J; Grajkowska W; Tyburczy ME; Jozwiak S; Kwiatkowski DJ; Aronica E; Jaworski J
Acta Neuropathol Commun; 2015 Jul; 3():48. PubMed ID: 26220190
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex.
Feliciano DM; Zhang S; Quon JL; Bordey A
Hum Mol Genet; 2013 May; 22(9):1725-34. PubMed ID: 23349360
[TBL] [Abstract][Full Text] [Related]
25. Modeling Neurodevelopmental Deficits in Tuberous Sclerosis Complex with Stem Cell Derived Neural Precursors and Neurons.
Sundberg M; Sahin M
Adv Neurobiol; 2020; 25():1-31. PubMed ID: 32578142
[TBL] [Abstract][Full Text] [Related]
26. Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion.
Feliciano DM; Quon JL; Su T; Taylor MM; Bordey A
Hum Mol Genet; 2012 Feb; 21(4):799-810. PubMed ID: 22068588
[TBL] [Abstract][Full Text] [Related]
27. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.
Goto J; Talos DM; Klein P; Qin W; Chekaluk YI; Anderl S; Malinowska IA; Di Nardo A; Bronson RT; Chan JA; Vinters HV; Kernie SG; Jensen FE; Sahin M; Kwiatkowski DJ
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):E1070-9. PubMed ID: 22025691
[TBL] [Abstract][Full Text] [Related]
28. Subependymal giant cell astrocytoma (SEGA): a case report and review of the literature.
Tahiri Elousrouti L; Lamchahab M; Bougtoub N; Elfatemi H; Chbani L; Harmouch T; Maaroufi M; Amarti Riffi A
J Med Case Rep; 2016 Feb; 10():35. PubMed ID: 26861567
[TBL] [Abstract][Full Text] [Related]
29. Biallelic TSC gene inactivation in tuberous sclerosis complex.
Crino PB; Aronica E; Baltuch G; Nathanson KL
Neurology; 2010 May; 74(21):1716-23. PubMed ID: 20498439
[TBL] [Abstract][Full Text] [Related]
30. Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.
Parker WE; Orlova KA; Heuer GG; Baybis M; Aronica E; Frost M; Wong M; Crino PB
Am J Pathol; 2011 Jan; 178(1):296-305. PubMed ID: 21224066
[TBL] [Abstract][Full Text] [Related]
31. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.
Peron A; Vignoli A; Briola F; Morenghi E; Tansini L; Alfano RM; Bulfamante G; Terraneo S; Ghelma F; Banderali G; Viskochil DH; Carey JC; Canevini MP;
Eur J Med Genet; 2018 Jul; 61(7):403-410. PubMed ID: 29432982
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.
Boer K; Troost D; Jansen F; Nellist M; van den Ouweland AM; Geurts JJ; Spliet WG; Crino P; Aronica E
Neuropathology; 2008 Dec; 28(6):577-90. PubMed ID: 18410267
[TBL] [Abstract][Full Text] [Related]
33. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
34. Neuropathology of tuberous sclerosis.
Mizuguchi M; Takashima S
Brain Dev; 2001 Nov; 23(7):508-15. PubMed ID: 11701246
[TBL] [Abstract][Full Text] [Related]
35. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.
Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Berkowitz N; Anak O; Niolat J; Jozwiak S
Lancet Oncol; 2014 Dec; 15(13):1513-1520. PubMed ID: 25456370
[TBL] [Abstract][Full Text] [Related]
36. Evidence for population variation in TSC1 and TSC2 gene expression.
Jentarra GM; Rice SG; Olfers S; Saffen D; Narayanan V
BMC Med Genet; 2011 Feb; 12():29. PubMed ID: 21345208
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical characterization of subependymal giant cell astrocytomas.
Lopes MB; Altermatt HJ; Scheithauer BW; Shepherd CW; VandenBerg SR
Acta Neuropathol; 1996; 91(4):368-75. PubMed ID: 8928613
[TBL] [Abstract][Full Text] [Related]
38. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
[TBL] [Abstract][Full Text] [Related]
39. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
[TBL] [Abstract][Full Text] [Related]
40. Subependymal giant cell astrocytoma in a genetically negative tuberous sclerosis complex adult: Case report.
Konakondla S; Jayarao M; Skrade J; Giannini C; Workman MJ; Morgan CJ
Clin Neurol Neurosurg; 2016 Nov; 150():177-180. PubMed ID: 27690251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
